Isolation of human anti-idiotypes broadly cross reactive with anti-dsDNA antibodies from patients with Systemic lupus erythematosus

被引:16
作者
Zhang, W
Winkler, T
Kalden, JR
Reichlin, M
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Med Res Fdn, Arthrit & Immunol Program, Oklahoma City, OK 73104 USA
[2] Univ Erlangen Nurnberg, Dept Med 3, D-91054 Erlangen, Germany
[3] Univ Erlangen Nurnberg, Inst Rheumatol & Clin Immunol, D-91054 Erlangen, Germany
[4] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA
关键词
D O I
10.1046/j.1365-3083.2001.00858.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antibodies to double stranded (ds)DNA play a central role in clinical diagnosis and disease expression in Systemic lupus erythematosus (SLE), This paper describes the isolation of anti-idiotype reagents (anti/antidsDNA) from four SLE sera and the demonstration of broad and quantitatively similar cross reactivity to both polyclonal and monoclonal anti-dsDNA antibodies isolated from SLE patients. Seven affinity-purified polyclonal and three monoclonal human anti-dsDNA preparations reacted preferentially with anti-idiotype F(ab')(2) coated plates compared to normal immunoglobulin (Ig)G F(ab')(2) coated plates in ELISA. In contrast, autoantibodies of other specificities (anti-Ro/SSA, anti-La/SSB, and anti-U1RNP) reacted equally with anti/anti-dsDNA F(ab')(2) and normal IgG F(ab')(2) coated plates. Such anti-idiotypic antibodies could play a significant role in the regulation of anti-dsDNA antibody levels in SLE.
引用
收藏
页码:192 / 197
页数:6
相关论文
共 31 条
[1]   NETWORK THEORY IN AUTOIMMUNITY - INVITRO SUPPRESSION OF SERUM ANTI-DNA ANTIBODY-BINDING TO DNA BY ANTI-IDIOTYPIC ANTIBODY IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ABDOU, NI ;
WALL, H ;
LINDSLEY, HB ;
HALSEY, JF ;
SUZUKI, T .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 67 (05) :1297-1304
[2]  
BLANK M, 1994, CLIN EXP IMMUNOL, V98, P434
[3]   INVITRO PRODUCTION OF AN ANTI-DNA IDIOTYPE BY LYMPHOCYTES OF NORMAL SUBJECTS AND PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
DATTA, SK ;
NAPARSTEK, Y ;
SCHWARTZ, RS .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1986, 38 (03) :302-318
[4]   NATURALLY-OCCURRING ANTI-IDIOTYPIC ANTIBODIES IN MYASTHENIA-GRAVIS PATIENTS [J].
DWYER, DS ;
BRADLEY, RJ ;
URQUHART, CK ;
KEARNEY, JF .
NATURE, 1983, 301 (5901) :611-614
[5]  
Ebling F M, 1989, Int Rev Immunol, V5, P79, DOI 10.3109/08830188909086990
[6]  
Hahn Bevra H., 1993, P195
[7]  
HAHN BH, 1984, J IMMUNOL, V132, P187
[8]  
HAHN BH, 1987, J IMMUNOL, V138, P2110
[9]  
HARLEY JB, 1989, ARTHRITIS RHEUM, V32, P826
[10]   ANTI-IDIOTYPIC ANTIBODIES AGAINST THE RECEPTOR ANTIBODIES IN MYASTHENIA-GRAVIS [J].
LEFVERT, AK .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1981, 13 (05) :493-497